Statement of Shareholders' Equity (Deficiency) (USD $)	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Deficit during Development Stage
Shareholders' deficiency, Beginning balance at Jan. 31, 2011	$ (120,756)	$ 274	$ 13,435	$ (134,465)	$ 0
Common stock, shares outstanding, Beginning balance at Jan. 31, 2011		274,190
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Payment of professional fees by shareholder	17,500	0	17,500	0	0
Conversion of convertible debt into common stock	36,000	959	35,041	0	0
Conversion of convertible debt into common stock, shares		959,663
Forgiveness of accrued interest on convertible debt	15,347	0	15,347	0	0
Net loss	(38,898)	0	0	(38,898)	0
Shareholders' deficiency, Ending balance at Jan. 31, 2012	(90,807)	1,233	81,323	(173,363)	0
Common stock, shares outstanding, Ending balance at Jan. 31, 2012	1,233,853	1,233,853
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(82,951)			(39,675)	(43,276)
Shareholders' deficiency, Ending balance at Jan. 31, 2013	$ (173,758)	$ 1,233	$ 81,323	$ (213,038)	$ (43,276)
Common stock, shares outstanding, Ending balance at Jan. 31, 2013	1,233,853	1,233,853